Document Detail


Corneal perforation associated with topically applied gatifloxacin.
MedLine Citation:
PMID:  18362672     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To document the development of corneal perforation after using gatifloxacin to treat inflamed pterygium. METHODS: A 30-year-old man developed corneal perforation after using gatifloxacin to treat inflamed pterygium. RESULTS: After treatment with gatifloxacin was stopped, the perforation was managed by applying cyanoacrylate glue, followed by pterygium excision. CONCLUSIONS: If used in the management of inflamed pterygium, gatifloxacin may predispose patients to corneal perforation.
Authors:
Abdulrahman Mohammed Al-Amri
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cornea     Volume:  27     ISSN:  0277-3740     ISO Abbreviation:  Cornea     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-25     Completed Date:  2008-05-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8216186     Medline TA:  Cornea     Country:  United States    
Other Details:
Languages:  eng     Pagination:  370-1     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, College of Medicine, King Khalid University, Abha, Saudi Arabia. amaamri@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Anti-Infective Agents / adverse effects*
Cornea / drug effects*
Corneal Diseases / chemically induced*
Fluoroquinolones / adverse effects*
Humans
Male
Pterygium / drug therapy
Rupture, Spontaneous
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 0/Fluoroquinolones; 112811-59-3/gatifloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Traumatic epithelial inclusion cyst of the anterior corneal stroma.
Next Document:  Histologic evaluation of a cornea in a patient with apolipoprotein A-I deficiency.